4.6 Article

Activated factor XI is associated with increased factor VIIa - Antithrombin complexes in stable coronary artery disease: Impact on cardiovascular outcomes

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients

Elzbieta Paszek et al.

Summary: This study found that active TF and FXIa were associated with clinical outcomes in CAD patients in long-term observation, and FXIa was an independent predictor of the composite endpoint.

ATHEROSCLEROSIS (2022)

Article Hematology

Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice

Anh T. P. Ngo et al.

Summary: The study indicates that pharmacological targeting of FXI can reduce atherogenesis in Ldlr(-/-) mice, preventing or slowing the progression of atherosclerosis.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Article Cardiac & Cardiovascular Systems

Smoking cessation in patients with established coronary artery disease: data from the POLASPIRE survey

Pawel Koziel et al.

Summary: Smoking cessation in patients with coronary artery disease is associated with decreased risk of cardiovascular events. Factors related to persistent smoking in these patients include older age, exposure to secondhand smoke, low socioeconomic status, lack of consultation with a cardiologist, and not participating in cardiac rehabilitation.

KARDIOLOGIA POLSKA (2021)

Review Hematology

Factor XI as a Target for New Anticoagulants

James C. Fredenburgh et al.

Summary: The article discusses the rationale for developing factor XI inhibitors, identifies the most advanced stage agents, describes the results of completed clinical trials and ongoing trials, highlighting opportunities and challenges for this new generation of anticoagulants.

HAMOSTASEOLOGIE (2021)

Review Medicine, General & Internal

Fibrin clot properties in coronary artery disease: new determinants and prognostic markers

Julie B. Larsen et al.

Summary: Despite advancements in diagnosis and treatment, coronary artery disease remains a leading cause of global mortality and morbidity. Factors such as smoking, hypercholesterolemia, and hypertension only partially explain the disease’s pathophysiology, with reduced endogenous fibrinolytic activity potentially playing a significant role. Research indicates that altered fibrin clot properties and impaired fibrinolysis may significantly contribute to the thromboembolic risk in CAD patients, suggesting a need for further investigation into potential improvements in treatment.

POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ (2021)

Article Medicine, General & Internal

Changes over time in the prevention of recurrent coronary artery disease in everyday practice

Jan W. Peksa et al.

Summary: The study compared the implementation of ESC guidelines for preventing recurrent CAD in the years 2011-2013 and 2016-2017, finding improvements in blood pressure and LDL cholesterol control but no significant changes in other main risk factors.

POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ (2021)

Review Cardiac & Cardiovascular Systems

Tissue factor in atherosclerosis and atherothrombosis

Steven P. Grover et al.

ATHEROSCLEROSIS (2020)

Review Hematology

Anticoagulant and signaling functions of antithrombin

Alireza R. Rezaie et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Review Cardiac & Cardiovascular Systems

Fourth universal definition of myocardial infarction (2018)

Kristian Thygesen et al.

EUROPEAN HEART JOURNAL (2019)

Article Cardiac & Cardiovascular Systems

Heart Disease and Stroke Statistics-2019 Update A Report From the American Heart Association

Emelia J. Benjamin et al.

CIRCULATION (2019)

Article Medicine, General & Internal

Atherosclerosis

Peter Libby et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

Review Hematology

Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis

Steven P. Grover et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)

Review Cardiac & Cardiovascular Systems

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

Karen A. Hicks et al.

CIRCULATION (2018)

Review Cardiac & Cardiovascular Systems

Oxidative stress and cardiovascular disease: new insights

Pasquale Pignatelli et al.

KARDIOLOGIA POLSKA (2018)

Review Hematology

An update on factor XI structure and function

Bassem M. Mohammed et al.

THROMBOSIS RESEARCH (2018)

Article Cardiac & Cardiovascular Systems

Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study

Cengiz Ozcan et al.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2018)

Article Hematology

Assessing Circulating Factor VIIa-Antithrombin Complexes in Acute Ischemic Stroke: A Pilot Study

Artur Slomka et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2017)

Review Medical Laboratory Technology

Factor VIIa-antithrombin complex: a possible new biomarker for activated coagulation

Luca Spiezia et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)

Review Hematology

Tissue Factor Pathway Inhibitor Multiple Anticoagulant Activities for a Single Protein

Alan E. Mast

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)

Article Pharmacology & Pharmacy

Involvement of the TP receptor in TNF-α-induced endothelial tissue factor expression

Serena Del Turco et al.

VASCULAR PHARMACOLOGY (2014)

Article Hematology

Mechanisms of Coronary Thrombosis in Cigarette Smoke Exposure

Rajat S. Barua et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)

Review Medicine, General & Internal

MECHANISMS OF DISEASE The Hemostatic System as a Modulator of Atherosclerosis

Julian Ilcheff Borissoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Cardiac & Cardiovascular Systems

Early Atherosclerosis Exhibits an Enhanced Procoagulant State

Julian Ilcheff Borissoff et al.

CIRCULATION (2010)

Article Hematology

Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis

Luca Spiezia et al.

THROMBOSIS AND HAEMOSTASIS (2010)

Article Hematology

Factor XIa and tissue factor activity in patients with coronary artery disease

Saulius Butenas et al.

THROMBOSIS AND HAEMOSTASIS (2008)

Review Hematology

The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking

D. M. Monroe et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

Article Public, Environmental & Occupational Health

Relaxing the rule of ten events per variable in logistic and Cox regression

Eric Vittinghoff et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)

Article Hematology

Immunologic quantitation of tissue factors

B. Parhami-Seren et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)

Article Hematology

The function of factor XI in tissue factor-initiated thrombin generation

S Butenas et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)